Literature DB >> 26998603

The Quality of Rare Disease Registries: Evaluation and Characterization.

Alessio Coi1, Michele Santoro, Ana Villaverde-Hueso, Michele Lipucci Di Paola, Sabina Gainotti, Domenica Taruscio, Manuel Posada de la Paz, Fabrizio Bianchi.   

Abstract

BACKGROUND: The focus on the quality of the procedures for data collection, storing, and analysis in the definition and implementation of a rare disease registry (RDR) is the basis for developing a valid and long-term sustainable tool. The aim of this study was to provide useful information for characterizing a quality profile for RDRs using an analytical approach applied to RDRs participating in the European Platform for Rare Disease Registries 2011-2014 (EPIRARE) survey.
METHODS: An indicator of quality was defined by choosing a small set of quality-related variables derived from the survey. The random forest method was used to identify the variables best defining a quality profile for RDRs. Fisher's exact test was employed to assess the association with the indicator of quality, and the Cochran-Armitage test was used to check the presence of a linear trend along different levels of quality.
RESULTS: The set of variables found to characterize high-quality RDRs focused on ethical and legal issues, governance, communication of activities and results, established procedures to regulate access to data and security, and established plans to ensure long-term sustainability.
CONCLUSIONS: The quality of RDRs is usually associated with a good oversight and governance mechanism and with durable funding. The results suggest that RDRs would benefit from support in management, information technology, epidemiology, and statistics.
© 2016 S. Karger AG, Basel.

Mesh:

Year:  2016        PMID: 26998603     DOI: 10.1159/000444476

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  8 in total

Review 1.  The case for open science: rare diseases.

Authors:  Yaffa R Rubinstein; Peter N Robinson; William A Gahl; Paul Avillach; Gareth Baynam; Helene Cederroth; Rebecca M Goodwin; Stephen C Groft; Mats G Hansson; Nomi L Harris; Vojtech Huser; Deborah Mascalzoni; Julie A McMurry; Matthew Might; Christoffer Nellaker; Barend Mons; Dina N Paltoo; Jonathan Pevsner; Manuel Posada; Alison P Rockett-Frase; Marco Roos; Tamar B Rubinstein; Domenica Taruscio; Esther van Enckevort; Melissa A Haendel
Journal:  JAMIA Open       Date:  2020-09-11

2.  An assessment of the quality of the I-DSD and the I-CAH registries - international registries for rare conditions affecting sex development.

Authors:  M Kourime; J Bryce; J Jiang; R Nixon; M Rodie; S F Ahmed
Journal:  Orphanet J Rare Dis       Date:  2017-03-20       Impact factor: 4.123

3.  Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID.

Authors:  Heide Stirnadel-Farrant; Mahesh Kudari; Nadia Garman; Jessica Imrie; Bikramjit Chopra; Stefania Giannelli; Michela Gabaldo; Ambra Corti; Stefano Zancan; Alessandro Aiuti; Maria Pia Cicalese; Rohit Batta; Jonathan Appleby; Mario Davinelli; Pauline Ng
Journal:  Orphanet J Rare Dis       Date:  2018-04-06       Impact factor: 4.123

4.  The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.

Authors:  Marie De Antonio; Céline Dogan; Ferroudja Daidj; Bruno Eymard; Jack Puymirat; Jean Mathieu; Cynthia Gagnon; Sandrine Katsahian; Dalil Hamroun; Guillaume Bassez
Journal:  Orphanet J Rare Dis       Date:  2019-06-03       Impact factor: 4.123

5.  The current landscape of European registries for rare endocrine conditions.

Authors:  S R Ali; J Bryce; M Cools; M Korbonits; J G Beun; D Taruscio; T Danne; M Dattani; O M Dekkers; A Linglart; I Netchine; A Nordenstrom; A Patocs; L Persani; N Reisch; A Smyth; Z Sumnik; W E Visser; O Hiort; A M Pereira; S F Ahmed
Journal:  Eur J Endocrinol       Date:  2019-01-01       Impact factor: 6.664

Review 6.  The EuRRECa Project as a Model for Data Access and Governance Policies for Rare Disease Registries That Collect Clinical Outcomes.

Authors:  Salma R Ali; Jillian Bryce; Li En Tan; Olaf Hiort; Alberto M Pereira; Erica L T van den Akker; Natasha M Appelman-Dijkstra; Jerome Bertherat; Martine Cools; Olaf M Dekkers; Yllka Kodra; Luca Persani; Arelene Smyth; Christopher Smythe; Domenica Taruscio; S Faisal Ahmed
Journal:  Int J Environ Res Public Health       Date:  2020-11-25       Impact factor: 3.390

7.  Recommendations for Improving the Quality of Rare Disease Registries.

Authors:  Yllka Kodra; Jérôme Weinbach; Manuel Posada-de-la-Paz; Alessio Coi; S Lydie Lemonnier; David van Enckevort; Marco Roos; Annika Jacobsen; Ronald Cornet; S Faisal Ahmed; Virginie Bros-Facer; Veronica Popa; Marieke Van Meel; Daniel Renault; Rainald von Gizycki; Michele Santoro; Paul Landais; Paola Torreri; Claudio Carta; Deborah Mascalzoni; Sabina Gainotti; Estrella Lopez; Anna Ambrosini; Heimo Müller; Robert Reis; Fabrizio Bianchi; Yaffa R Rubinstein; Hanns Lochmüller; Domenica Taruscio
Journal:  Int J Environ Res Public Health       Date:  2018-08-03       Impact factor: 3.390

8.  European lipodystrophy registry: background and structure.

Authors:  Julia von Schnurbein; Claire Adams; Baris Akinci; Giovanni Ceccarini; Maria Rosaria D'Apice; Alessandra Gambineri; Raoul C M Hennekam; Isabelle Jeru; Giovanna Lattanzi; Konstanze Miehle; Gabriele Nagel; Giuseppe Novelli; Ferruccio Santini; Ermelinda Santos Silva; David B Savage; Paolo Sbraccia; Jannik Schaaf; Ekaterina Sorkina; George Tanteles; Marie-Christine Vantyghem; Camille Vatier; Corinne Vigouroux; Elena Vorona; David Araújo-Vilar; Martin Wabitsch
Journal:  Orphanet J Rare Dis       Date:  2020-01-15       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.